MetaCap

Sera Prognostics Inc. Class A Company Profile

NASDAQ: SERAHealth CareMedical SpecialitiesUSD

1.81-0.08 (-4.23%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Sera Prognostics at a glance

Sera Prognostics Inc. Class A (NASDAQ: SERA) is a Medical Specialities company in the Health Care sector headquartered in Salt Lake City, UT. Sera Prognostics is led by Ms. Zhenya Lindgardt M.B.A. and employs about 71 people. The company's shares have traded publicly since 2021.

At a market capitalization of $72.0 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001534969, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Sera Prognostics do?

Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Business description based on the company's public filings.

Company information

Legal name
Sera Prognostics Inc. Class A
Ticker
NASDAQ: SERA
Industry
Medical Specialities
CEO
Ms. Zhenya Lindgardt M.B.A.
Employees
71
Headquarters
2749 East Parleys Way, Salt Lake City, UT, United States
Phone
801 990 0520
Website
sera.com
IPO year
2021
Market cap
$71.98M
SEC CIK
0001534969
Latest annual report
10-K · Mar 18, 2026

Companies similar to Sera Prognostics

SERA peer companies
CompanyPrice% ChgMarket capCompare
BDSXBiodesix Inc.7.56-8.92%$83.83Mvs SERA
XGNExagen Inc.3.61-5.00%$92.10Mvs SERA
KEQUKewaunee Scientific Corporation33.55-2.75%$97.14Mvs SERA
MDXHMDxHealth SA0.1074-8.52%$10.25Mvs SERA
AMSAmerican Shared Hospital Services1.00-4.76%$6.67Mvs SERA
BNRBurning Rock Biotech Limited ADR13.24-0.60%$139.63Mvs SERA
ACONAclarion Inc.1.22-13.92%$3.52Mvs SERA
ADVBAdvanced Biomed Inc.1.65-5.71%$2.73Mvs SERA

Related